ARDT

Ardent Health Partners, Inc.
ARDT

$18.22

5.05%

Market Cap: $2.6B

About: Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.

Healthcare General Medical & Surgical Hospitals

–

Funds holding %

of 6,710 funds

0

Analysts bullish %

of 12 analysts

Fund manager confidence

See Fund Rankings

Research analyst outlook

12 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$18

1%

downside

Avg. target

$22

19%

upside

High target

$27

48%

upside

12 analyst ratings

11 positive

92%

1 neutral

8%

0 negative

0%

Truist Securities David Macdonald 91% 1-year accuracy 32 / 35 met price target	21%upside $22	Buy Reiterated	16 Aug 2024
Loop Capital Timothy Greaves 100% 1-year accuracy 2 / 2 met price target	15%upside $21	Buy Maintained	16 Aug 2024
Stephens & Co. Scott Fidel 90% 1-year accuracy 28 / 31 met price target	32%upside $24	Overweight Reiterated	15 Aug 2024
B of A Securities Kevin Fischbeck 78% 1-year accuracy 7 / 9 met price target	21%upside $22	Buy Initiated	12 Aug 2024
RBC Capital Ben Hendrix 82% 1-year accuracy 49 / 60 met price target	26%upside $23	Outperform Initiated	12 Aug 2024

See Analyst Rankings

Financial journalist opinion

Based on 4 articles about ARDT published over the past 30 days

Ardent Health Appoints Dave Styblo to Lead Investor Relations

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) today announced the appointment of Dave Styblo as senior vice president of investor relations. In his new role, Styblo will oversee Ardent's investor relations program and serve as the primary liaison with investors, analysts and financial partners. Styblo brings more than 20 years of investment experience, including time as a sell-side analyst covering the healthcare industry. He previously served as a senior vice president at Jeffe.

Ardent Health Appoints Dave Styblo to Lead Investor Relations

Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference being held September 4-6, 2024, in New York, NY. Ardent Health President and Chief Executive Officer Marty Bonick and Chief Financial Officer Alfred Lumsdaine will take part in a fireside c.

Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Ardent Health Reports Second Quarter 2024 Results

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Summary (All comparisons versus the same prior year period, unless otherwise noted) Total revenue of $1.47 billion, an increase of 7.5% Net income of $67 million Net income attributable to Ardent Hea.

Ardent Health Reports Second Quarter 2024 Results

New Hospital Operator On The Block Ardent Health Garners Interest As Analysts Initiate With Bullish View

In July, Ardent Health Partners Inc. ARDT closed its initial public offering of 12 million at a public offering price of $16 per share, for total gross proceeds of approximately $192 million.

New Hospital Operator On The Block Ardent Health Garners Interest As Analysts Initiate With Bullish View

Ardent Health Announces Second Quarter 2024 Results Conference Call and Webcast Date

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that it will issue its second quarter 2024 results after the market closes on Wednesday, August 14, 2024. A conference call will be held the following day, Thursday, August 15, 2024, at 10:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a ques.

Ardent Health Announces Second Quarter 2024 Results Conference Call and Webcast Date

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

A handful of IPOs priced this past week, led by three sizable names. One large issuer joined both the pipeline and the calendar - Chile-based LATAM Airlines Group. Six IPOs are scheduled to list in the week ahead and are set to raise a combined $5.1 billion, the most for any week so far this year. One SPAC is also set to debut.

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

Ardent Health Announces Closing of Its Initial Public Offering

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (f/k/a Ardent Health Partners, LLC and collectively “Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced the closing of its initial public offering (the “Offering”) of 12,000,000 shares of its common stock sold by the Company at a public offering price of $16 per share, for total gross proceeds of approximately $192 million, before ded.

Ardent Health Announces Closing of Its Initial Public Offering

Ardent Health falls 6% in lukewarm NYSE debut

Healthcare provider Ardent Health's shares opened 6% below their initial public offering price in their NYSE debut on Thursday, reflecting new investor caution with new listings amid rate cut uncertainties.

Ardent Health falls 6% in lukewarm NYSE debut

Ardent Health IPO: Stock price today as hospitals and healthcare provider debuts on the NYSE

Another high-profile healthcare-related IPO is taking place this week. Here's what you ned to know about Ardent Health Partners and its initial public offering:

Ardent Health IPO: Stock price today as hospitals and healthcare provider debuts on the NYSE

Ardent Health prices US IPO below target range to raise $192 mln

Healthcare provider Ardent Health said on Wednesday it has set the pricing of its initial public offering below its targeted range to raise around $192 million.

Ardent Health prices US IPO below target range to raise $192 mln

See News Rankings